You are here

Article metrics

Article menu
Download PDFPDF
Editorial commentary
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?

 

Online download statistics by month:

Online download statistics by month: October 2015 to March 2024

AbstractFullPdf
Oct 20151472425
Nov 20152094268
Dec 2015821137
Jan 201638959155
Feb 20162033882
Mar 20161052837
Apr 201664820
May 2016671830
Jun 201662919
Jul 2016691011
Aug 201662913
Sep 201662610
Oct 201657117
Nov 2016611015
Dec 201644712
Jan 2017391112
Feb 201755161
Mar 2017332314
Apr 201725115
May 201742175
Jun 201750106
Jul 20176621
Aug 20176463
Sep 20178041
Oct 201773146
Nov 20177742
Dec 20173911
Jan 20186398
Feb 20188410
Mar 20185941
Apr 201882171
May 20189655
Jun 20188411
Jul 20187133
Aug 20189942
Sep 20184230
Oct 20183730
Nov 20184274
Dec 20185430
Jan 20193630
Feb 20191110
Mar 20192930
Apr 20192520
May 20192611
Jun 20193020
Jul 20193262
Aug 20192200
Sep 20194010
Oct 20195630
Nov 20193943
Dec 20195341
Jan 20204442
Feb 20207410
Mar 20203635
Apr 20201220
May 20205021
Jun 20202020
Jul 20203210
Aug 20203630
Sep 20203620
Oct 20203120
Nov 20202800
Dec 20202700
Jan 20213100
Feb 20213621
Mar 20212810
Apr 20212330
May 20211753
Jun 2021222
Jul 2021110
Aug 2021210
Sep 2021322
Oct 20212300
Nov 20212810
Dec 20212021
Jan 20223010
Feb 20223021
Mar 20221812
Apr 20221302
May 20225312
Jun 20225610
Jul 20223111
Aug 20226840
Sep 20224962
Oct 202211510
Nov 20224710
Dec 20221630
Jan 20231911
Feb 20236010
Mar 20231600
Apr 20239402
May 20232711
Jun 20232210
Jul 20232220
Aug 20232520
Sep 20232011
Oct 20232000
Nov 20232000
Dec 20234310
Jan 20241630
Feb 20242300
Mar 20242410
Total5155577662